214 related articles for article (PubMed ID: 27542409)
1. Mechanistic Basis of Glutaminase Activation: A KEY ENZYME THAT PROMOTES GLUTAMINE METABOLISM IN CANCER CELLS.
Li Y; Erickson JW; Stalnecker CA; Katt WP; Huang Q; Cerione RA; Ramachandran S
J Biol Chem; 2016 Sep; 291(40):20900-20910. PubMed ID: 27542409
[TBL] [Abstract][Full Text] [Related]
2. High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding.
Nguyen TT; Ramachandran S; Hill MJ; Cerione RA
J Biol Chem; 2022 Feb; 298(2):101564. PubMed ID: 34999118
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism.
Huang Q; Stalnecker C; Zhang C; McDermott LA; Iyer P; O'Neill J; Reimer S; Cerione RA; Katt WP
J Biol Chem; 2018 Mar; 293(10):3535-3545. PubMed ID: 29317493
[TBL] [Abstract][Full Text] [Related]
4. The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled.
Li Y; Ramachandran S; Nguyen TT; Stalnecker CA; Cerione RA; Erickson JW
J Biol Chem; 2020 Jan; 295(5):1328-1337. PubMed ID: 31871054
[TBL] [Abstract][Full Text] [Related]
5. Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators.
Stalnecker CA; Erickson JW; Cerione RA
J Biol Chem; 2017 Apr; 292(15):6095-6107. PubMed ID: 28196863
[TBL] [Abstract][Full Text] [Related]
6. N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migration.
Ascenção CFR; Nagampalli RSK; Islam Z; Pinheiro MP; Menezes Dos Reis L; Pauletti BA; de Guzzi Cassago CA; Granato DC; Paes Leme AF; Dias SMG
Biochimie; 2018 Nov; 154():69-76. PubMed ID: 30092248
[TBL] [Abstract][Full Text] [Related]
7. Structure and activation mechanism of the human liver-type glutaminase GLS2.
Ferreira IM; Quesñay JEN; Bastos AC; Rodrigues CT; Vollmar M; Krojer T; Strain-Damerell C; Burgess-Brown NA; von Delft F; Yue WW; Dias SM; Ambrosio AL
Biochimie; 2021 Jun; 185():96-104. PubMed ID: 33746066
[TBL] [Abstract][Full Text] [Related]
8. Active glutaminase C self-assembles into a supratetrameric oligomer that can be disrupted by an allosteric inhibitor.
Ferreira AP; Cassago A; Gonçalves Kde A; Dias MM; Adamoski D; Ascenção CF; Honorato RV; de Oliveira JF; Ferreira IM; Fornezari C; Bettini J; Oliveira PS; Paes Leme AF; Portugal RV; Ambrosio AL; Dias SM
J Biol Chem; 2013 Sep; 288(39):28009-20. PubMed ID: 23935106
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism.
Cassago A; Ferreira AP; Ferreira IM; Fornezari C; Gomes ER; Greene KS; Pereira HM; Garratt RC; Dias SM; Ambrosio AL
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):1092-7. PubMed ID: 22228304
[TBL] [Abstract][Full Text] [Related]
10. Lid L11 of the glutamine amidotransferase domain of CTP synthase mediates allosteric GTP activation of glutaminase activity.
Willemoës M; Mølgaard A; Johansson E; Martinussen J
FEBS J; 2005 Feb; 272(3):856-64. PubMed ID: 15670165
[TBL] [Abstract][Full Text] [Related]
11. Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells.
Stalnecker CA; Ulrich SM; Li Y; Ramachandran S; McBrayer MK; DeBerardinis RJ; Cerione RA; Erickson JW
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):394-9. PubMed ID: 25548170
[TBL] [Abstract][Full Text] [Related]
12. Filament formation drives catalysis by glutaminase enzymes important in cancer progression.
Feng S; Aplin C; Nguyen TT; Milano SK; Cerione RA
Nat Commun; 2024 Mar; 15(1):1971. PubMed ID: 38438397
[TBL] [Abstract][Full Text] [Related]
13. Full-length human glutaminase in complex with an allosteric inhibitor.
DeLaBarre B; Gross S; Fang C; Gao Y; Jha A; Jiang F; Song J J; Wei W; Hurov JB
Biochemistry; 2011 Dec; 50(50):10764-70. PubMed ID: 22049910
[TBL] [Abstract][Full Text] [Related]
14. New insights into the molecular mechanisms of glutaminase C inhibitors in cancer cells using serial room temperature crystallography.
Milano SK; Huang Q; Nguyen TT; Ramachandran S; Finke A; Kriksunov I; Schuller DJ; Szebenyi DM; Arenholz E; McDermott LA; Sukumar N; Cerione RA; Katt WP
J Biol Chem; 2022 Feb; 298(2):101535. PubMed ID: 34954143
[TBL] [Abstract][Full Text] [Related]
15. Dissection of contributions from invariant amino acids to complex formation and catalysis in the heteromeric pyridoxal 5-phosphate synthase complex from Bacillus subtilis.
Wallner S; Neuwirth M; Flicker K; Tews I; Macheroux P
Biochemistry; 2009 Mar; 48(9):1928-35. PubMed ID: 19152323
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanism of glutaminase activation through filamentation and the role of filaments in mitophagy protection.
Adamoski D; Dias MM; Quesñay JEN; Yang Z; Zagoriy I; Steyer AM; Rodrigues CT; da Silva Bastos AC; da Silva BN; Costa RKE; de Abreu FMO; Islam Z; Cassago A; van Heel MG; Consonni SR; Mattei S; Mahamid J; Portugal RV; Ambrosio ALB; Dias SMG
Nat Struct Mol Biol; 2023 Dec; 30(12):1902-1912. PubMed ID: 37857822
[TBL] [Abstract][Full Text] [Related]
17. Limited proteolysis of Escherichia coli cytidine 5'-triphosphate synthase. Identification of residues required for CTP formation and GTP-dependent activation of glutamine hydrolysis.
Simard D; Hewitt KA; Lunn F; Iyengar A; Bearne SL
Eur J Biochem; 2003 May; 270(10):2195-206. PubMed ID: 12752439
[TBL] [Abstract][Full Text] [Related]
18. "Pinching" the ammonia tunnel of CTP synthase unveils coordinated catalytic and allosteric-dependent control of ammonia passage.
McCluskey GD; Bearne SL
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2714-2727. PubMed ID: 30251661
[TBL] [Abstract][Full Text] [Related]
19. Crystal structures capture three states in the catalytic cycle of a pyridoxal phosphate (PLP) synthase.
Smith AM; Brown WC; Harms E; Smith JL
J Biol Chem; 2015 Feb; 290(9):5226-39. PubMed ID: 25568319
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the active site inhibition mechanism of human kidney-type glutaminase (KGA).
Thangavelu K; Chong QY; Low BC; Sivaraman J
Sci Rep; 2014 Jan; 4():3827. PubMed ID: 24451979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
